Prasugrel Hydrochloride (CAS 389574-19-0)

Prasugrel Hydrochloride irreversibly binds to P2Y12 receptors and inhibits platelets. This chemical is a novel third-generation thienopyridine. Prasugrel hydrochloride showed greater platelet inhibition and decreased incidence of ischemic events when compared to clopidogrel. Prasugrel Hydrochloride is an inhibitor of P2Y12.

Literaturhinweise

Von Beckerath, N., et al.: Circulation, 112, 2946 (2005), Jernberg, T., et al.: Eur. Heart J., 27, 1166 (2006), Farid, N., et al.: Drug Metab. Dispos., 35, 1096 (2007), Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2007), Jakubowski, J., et al.: J. Cardiovasc. Pharmacol., 49, 167 (2007), Wiviott, S., et al.: N. Engl. J. Med., 357, 2001 (2007),